Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT01729754||Active, not recruiting
|A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222) in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Followed by a Long-term Extension Study (MK-3222-011)||
||1090||All||18 Years and older (Adult, Older Adult)||NCT01729754||3222-011
|reSURFACE 2||February 5, 2013||December 20, 2014||December 4, 2020||November 20, 2012||May 3, 2019||June 27, 2018|